CN101014322A - 盐水中富含固醇的添加两性霉素的混合层状脂质体及其制备方法 - Google Patents

盐水中富含固醇的添加两性霉素的混合层状脂质体及其制备方法 Download PDF

Info

Publication number
CN101014322A
CN101014322A CNA200580023366XA CN200580023366A CN101014322A CN 101014322 A CN101014322 A CN 101014322A CN A200580023366X A CNA200580023366X A CN A200580023366XA CN 200580023366 A CN200580023366 A CN 200580023366A CN 101014322 A CN101014322 A CN 101014322A
Authority
CN
China
Prior art keywords
amphotericin
sterol
rich
liposome
ergosterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200580023366XA
Other languages
English (en)
Chinese (zh)
Inventor
吉藤德拉·纳提·维玛
莉莉·维玛
库里山·库马尔·特里帕提
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifecare Innovations Pvt Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN101014322A publication Critical patent/CN101014322A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CNA200580023366XA 2004-06-11 2005-06-13 盐水中富含固醇的添加两性霉素的混合层状脂质体及其制备方法 Pending CN101014322A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1113DE2004 2004-06-11
IN1113/DEL/2004 2004-06-11

Publications (1)

Publication Number Publication Date
CN101014322A true CN101014322A (zh) 2007-08-08

Family

ID=34972096

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200580023366XA Pending CN101014322A (zh) 2004-06-11 2005-06-13 盐水中富含固醇的添加两性霉素的混合层状脂质体及其制备方法

Country Status (9)

Country Link
US (1) US20070218119A1 (enExample)
EP (1) EP1771156B8 (enExample)
JP (1) JP4966855B2 (enExample)
CN (1) CN101014322A (enExample)
AT (1) ATE476965T1 (enExample)
AU (1) AU2005251572B2 (enExample)
BR (1) BRPI0511371A (enExample)
DE (1) DE602005022876D1 (enExample)
WO (1) WO2005120460A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1003990B1 (pt) * 2009-10-16 2021-09-14 Lifecare Innovations Pvt. Ltd Formulação para o tratamento de infecções fúngicas
CN108602025B (zh) 2016-03-04 2021-02-26 栗田工业株式会社 选择性透过膜及其制造方法、使用该选择性透过膜的水处理方法
PT3694526T (pt) 2017-10-11 2025-01-20 Univ Illinois Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas
IL315719A (en) 2022-03-21 2024-11-01 Univ Illinois Prosthetic assemblies of ion channels containing lipid-coated amphotericin B crystals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2134869A (en) * 1983-02-15 1984-08-22 Squibb & Sons Inc Method of preparing liposomes and products produced thereby
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method

Also Published As

Publication number Publication date
EP1771156A1 (en) 2007-04-11
WO2005120460A1 (en) 2005-12-22
AU2005251572B2 (en) 2010-03-11
AU2005251572A1 (en) 2005-12-22
BRPI0511371A (pt) 2008-03-11
US20070218119A1 (en) 2007-09-20
JP2008501782A (ja) 2008-01-24
EP1771156B1 (en) 2010-08-11
JP4966855B2 (ja) 2012-07-04
ATE476965T1 (de) 2010-08-15
DE602005022876D1 (de) 2010-09-23
EP1771156B8 (en) 2010-09-15

Similar Documents

Publication Publication Date Title
DK168982B1 (da) Fremgangsmåde til dannelse af små vesikler, der omfatter et phospholipid og indkapsler et antifungalt polyen-antibiotikum, og præparat dannet ved denne fremgangsmåde til anvendelse ved en fremgangsmåde til behandling af systemiske fungale infektioner
US4877619A (en) Liposomal vesicles for intraperitoneal administration of therapeutic agents
JP3202999B2 (ja) 肝移行性リポソーム製剤
JP4598908B2 (ja) カチオン性リポソームとポリデオキシリボヌクレオチドとの複合体
CN1655764A (zh) 用于给予一定大小的脂质体治疗或预防疾病的组合物和方法
FI3821887T3 (fi) Mitoksantroni liposomin käyttö ei-hodgkinin lymfooman hoitoon
KR101901083B1 (ko) 외이도염의 신속한 치료를 위한 방법 및 조성물
Chance New developments in the chemotherapy of leishmaniasis
AU2008331500B2 (en) Intravesical compositions with valrubicin for the treatment of bladder cancer
EP4501316A1 (en) Gemcitabine liposome pharmaceutical composition, preparation method therefor and use thereof
JP5729735B2 (ja) ダルセトラピブのリポソーム製剤
US20120207821A1 (en) Liposomal formulation and use thereof
AU2005251572B2 (en) Sterol enriched mixed lammelarity Amphotericin intercalating liposomes in saline and the process for their preparation
US9011924B2 (en) Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
JP3272736B2 (ja) リポソーム製剤
JP2004504346A (ja) 骨転移の治療におけるリン酸エストラムスチンの使用
WO1993023015A1 (en) Liposomal aminoglycoside compositions and process for their preparation
Wasan et al. Targeted liposomes in fungi: modifying the therapeutic index of amphotericin B by its incorporation into negatively charged liposomes
TW202143978A (zh) 格列本脲脂質體組合物及其製備方法
Tan et al. Sustained tissue drug concentrations following inhalation of liposome-encapsulated fentanyl in rabbits
WASAN et al. The development of liposomal amphotericin B: an historical perspective
WO2013131164A1 (pt) Composição farmacêutica contendo lipossomas convencionais e lipossomas de circulação prolongada para o tratamento da leishmaniose visceral
WO2007014150A2 (en) Method of administering liposomes containing oligonucleotides
NO870299L (no) Liposom/antrakinon-legemiddelpreparat og fremgangsmaate for dets fremstilling.
JPWO1995024201A1 (ja) リポソーム製剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: LIFECARE INNOVATIONS PVT.CO.,LTD.

Free format text: FORMER OWNER: GETENDRA NATI VEMMA

Effective date: 20100504

Free format text: FORMER OWNER: LILY VEMMA KURISON KUMAR TERIPATY

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20100504

Address after: Haryana

Applicant after: Lifecare Innovations Pvt Ltd.

Address before: Haryana

Applicant before: Verma Jitendra Nath

Co-applicant before: Verma Lily

Co-applicant before: Tripathi Krishan Kumar

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20070808